Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 49.25
+0.65 (1.34%)
At close: Apr 17, 2026
Pet Pharm Biotech Revenue
In the year 2025, Pet Pharm Biotech had annual revenue of 222.03M TWD with 69.88% growth. Pet Pharm Biotech had revenue of 137.77M in the half year ending December 31, 2025.
Revenue
222.03M
Revenue Growth
+69.88%
P/S Ratio
12.76
Revenue / Employee
4.93M
Employees
45
Market Cap
2.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 222.03M | 91.33M | 69.88% |
| Dec 31, 2024 | 130.70M | 12.83M | 10.89% |
| Dec 31, 2023 | 117.87M | 42.13M | 55.62% |
| Dec 31, 2022 | 75.74M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition